Skip to content

Study on Unani Medicine Treatment and Effectiveness in Common Skin Diseases

Study of Drug Prescribing Pattern and Treatment Effectiveness of Common Skin Diseases in Unani Medicine : A Cross Sectional Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097200
Enrollment
500
Registered
2025-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified Health Condition 2: L209- Atopic dermatitis, unspecified Health Condition 3: L80- Vitiligo Health Condition 4: L814- Other melanin hyperpigmentation Health Condition 5: L509- Urticaria, unspecified Health Condition 6: B86- Scabies Health Condition 7: B354- Tinea corporis Health Condition 8: L709- Acne, unspecified

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

National Institute Of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of any gender and aged diagnosed with common skin diseases (psoriasis, vitiligo, eczema, melasma, tinea, acne, scabies, and urticaria) in OPD Department of Dermatology in NIUM hospital bengaluru. 2.Patients who are receiving Unani treatment for at least 4 weeks for tinea,acne,scabies,urticaria, eczema and for 12 weeks for vitiligo,melasma,psoriasis. 3.Patients who will be willing to participate and provided informed written consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1.Bullous skin disease, Impetigo,cellulitis, Rosacea,Warts,Pityriasis,Skin cancer. 2. Severe cases of common skin diseases.

Design outcomes

Primary

MeasureTime frame
Prescription pattern Average number of drugs per encounter, Class, Frequency ,dosage of drugs,Mode of drug administration, ,percentage of encounter with topical and oral drugs will be collected from patients prescription record. Timepoint: 18 month

Secondary

MeasureTime frame
Treatment Effectiveness 1.Clinical Improvement 2.Quality of life improvement 3.Patient Satisfaction level with Unani Treatment Timepoint: 18 month

Countries

India

Contacts

Public ContactDr Kausar Abdul Karim Mistry

National Institute of Unani medicine

Arish_sherwani@yahoo.co.in9448794691

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026